Advanced Technology Platform Covaris' proprietary AFA technology offers unique non-contact, isothermal ultrasonic processes widely adopted in genomics, proteomics, and drug discovery, creating multiple opportunities to cross-sell complementary research tools and consumables.

Strategic Acquisition Edge Following its acquisition by PerkinElmer and partnership with New Mountain Capital, Covaris is positioned for expanded distribution channels and increased market reach, enabling sales teams to capitalize on its growth momentum and broader customer base.

Product Innovation The launch of automatable workflows and new viral RNA kits demonstrates commitment to innovation, presenting opportunities to promote updated or complementary sample preparation and molecular biology products to existing and new clients.

Global Customer Base With thousands of ultrasonicators in use across over 30 countries and clients including top research institutions and pharmaceutical companies, there is high potential to expand into underserved markets and leverage international partnerships.

Emerging Market Demand Recent investments and launches in genomic and proteomic tools indicate a growing demand for advanced sample prep technologies, creating avenues for upselling high-throughput systems and customized solutions to research laboratories and biotech companies.